QEII Halifax Infirmary Emergency Department is working with reduced space, which may lead to delays for those with less urgent concerns. Learn more here.

Nova Scotia Health has made changes to parking and the main entrance of the QEII Halifax Infirmary. Learn more.

Risankizumab (Skyrizi®) Therapy for Inflammatory Bowel Disease (IBD)

Categories

Medications

Digestive System

Attachment

Last Update

July 1, 2023

Extension

.pdf

Print Code

QV85-2345

Language

English

Creator

Nova Scotia Collaborative Inflammatory Bowel Disease Program

Risankizumab is a biologic medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it.

Employee Resources